SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting

Kirsten E. Lyke, Robert L. Atmar, Clara Dominguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul PaulChourdhury, Meagan E. Deming, Amanda Eaton, Lisa A. Jackson, Angela R. Branche, Hana M. El Sahly, Christina A. Rostad, Judith M. Martin, Christine Johnston, Richard E. Rupp, Mark J. Mulligan, Rebecca C. Brady, Robert W. Frenck Jr., Martín Bäcker, Angelica C. Kottkamp, Tara M. Babu, Kumaravel Rajakumar, Srilatha Edupuganti, David Dobrzynski, Rhea N. Coler, Janet I. Archer, Sonja Crandon, Jillian A. Zemanek, Elizabeth R. Brown, Kathleen M. Neuzil, David S. Stephens, Diane J. Post, Seema U. Nayak, Paul C. Roberts, John H. Beigel, David Montefiori, the DMID 21-0012 Study Group
doi: https://doi.org/10.1101/2022.01.13.22268861

Article Information

doi 
https://doi.org/10.1101/2022.01.13.22268861
History 
  • January 14, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Kirsten E. Lyke, M.D.1,*,†,
  2. Robert L. Atmar, M.D.2,*,†,
  3. Clara Dominguez Islas, Ph.D.3,
  4. Christine M. Posavad, Ph.D.3,4,
  5. Daniel Szydlo, M.S.5,
  6. Rahul PaulChourdhury5,
  7. Meagan E. Deming, M.D., Ph.D.1,
  8. Amanda Eaton6,
  9. Lisa A. Jackson, M.D., M.P.H.7,
  10. Angela R. Branche, M.D.8,
  11. Hana M. El Sahly, M.D.2,
  12. Christina A. Rostad, M.D.9,
  13. Judith M. Martin, M.D.10,
  14. Christine Johnston, M.D, M.P.H.3,4,11,
  15. Richard E. Rupp, M.D.12,
  16. Mark J. Mulligan, MD13,
  17. Rebecca C. Brady, M.D.14,
  18. Robert W. Frenck Jr., M.D.14,
  19. Martín Bäcker, MD15,
  20. Angelica C. Kottkamp, MD13,
  21. Tara M. Babu, MD, MSc11,
  22. Kumaravel Rajakumar, M.D.10,
  23. Srilatha Edupuganti, M.D.16,17,
  24. David Dobrzynski, M.D.8,
  25. Rhea N. Coler, M.Sc., Ph.D.18,19,
  26. Janet I. Archer, M.Sc.20,
  27. Sonja Crandon, B.S.N.21,
  28. Jillian A. Zemanek, M.P.H.5,
  29. Elizabeth R. Brown, Sc.D.3,
  30. Kathleen M. Neuzil, M.D.1,
  31. David S. Stephens, M.D.16,
  32. Diane J. Post, Ph.D.21,
  33. Seema U. Nayak, M.D.21,
  34. Paul C. Roberts, Ph.D.21,
  35. John H. Beigel, M.D.21,*,
  36. David Montefiori, Ph.D.6,22,*,
  37. the DMID 21-0012 Study Group**
  1. 1Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD
  2. 2Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX
  3. 3Vaccine and Infectious Disease Division, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA
  4. 4Departments of Laboratory Medicine & Pathology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA
  5. 5Statistical Center for HIV/AIDS Research and Prevention (SCHARP), University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA
  6. 6Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC
  7. 7Kaiser Permanente Washington Health Research Institute, Seattle, WA
  8. 8Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY
  9. 9Department of Pediatrics and Center for Childhood Infections and Vaccines, Emory University School of Medicine and Children’s Healthcare of Atlanta, Atlanta, GA
  10. 10Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA
  11. 11Department of Medicine, University of Washington, Seattle, WA
  12. 12Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX
  13. 13NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY
  14. 14Cincinnati Children’s Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH
  15. 15NYU Langone Hospital—Long Island Vaccine Center Research Clinic and Division of Infectious Disease, Department of Medicine, NYU Long Island School of Medicine, Mineola, NY
  16. 16Department of Medicine, Emory University School of Medicine, Atlanta, GA
  17. 17Hope Clinic of Emory Vaccine Center, Atlanta, GA
  18. 18Seattle Children’s Research Institute, University of Washington School of Medicine, Seattle WA
  19. 19Department of Pediatrics, University of Washington School of Medicine, Seattle WA
  20. 20FHI360, Durham, NC 27701
  21. 21Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
  22. 22Department of Surgery, Duke University Medical Center, Durham, NC
  1. ↵†Corresponding Authors:
    Kirsten E. Lyke, M.D., Center for Vaccine Development and Global Health, 685 W. Baltimore Street, Baltimore, MD 21201, Phone: +1 410-706-0462/5328 and Robert L. Atmar, M.D., 1 Baylor Plaza, MSBCM280, Houston, TX 77030, Phone: +1 713-798-6849, Email: ratmar{at}bcm.edu

  1. ↵* First and Senior authors contributed equally to the work

Back to top
Posted January 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting
Kirsten E. Lyke, Robert L. Atmar, Clara Dominguez Islas, Christine M. Posavad, Daniel Szydlo, Rahul PaulChourdhury, Meagan E. Deming, Amanda Eaton, Lisa A. Jackson, Angela R. Branche, Hana M. El Sahly, Christina A. Rostad, Judith M. Martin, Christine Johnston, Richard E. Rupp, Mark J. Mulligan, Rebecca C. Brady, Robert W. Frenck Jr., Martín Bäcker, Angelica C. Kottkamp, Tara M. Babu, Kumaravel Rajakumar, Srilatha Edupuganti, David Dobrzynski, Rhea N. Coler, Janet I. Archer, Sonja Crandon, Jillian A. Zemanek, Elizabeth R. Brown, Kathleen M. Neuzil, David S. Stephens, Diane J. Post, Seema U. Nayak, Paul C. Roberts, John H. Beigel, David Montefiori, the DMID 21-0012 Study Group
medRxiv 2022.01.13.22268861; doi: https://doi.org/10.1101/2022.01.13.22268861
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area